Bundled Messaging for Colon Cancer Screening

IR
Overseen ByIlana Richman, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Yale University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial seeks to determine the most effective method for reminding individuals to complete their colorectal cancer screenings. It evaluates various message types, such as texts and letters, to identify which encourages more people to complete their tests. This method is known as a "bundled messaging intervention." Patients at Cornell Scott Hill Health with incomplete or abnormal colorectal screenings may find this trial suitable. As an unphased trial, it provides a unique opportunity to contribute to research that could enhance screening reminders for all.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It seems focused on improving cancer screening adherence, so it's unlikely to require changes to your medication.

What prior data suggests that this messaging intervention is safe for improving adherence to colorectal cancer screening?

Research has shown that the bundled messaging approach for colorectal cancer screening is safe for participants. This method sends messages and reminders to encourage patients to complete their screenings. Since it focuses on communication rather than medical treatment, no reports of physical side effects or negative reactions exist. Participants receive a series of text messages, letters, and reminders from their doctors, which are generally well-received. Strong evidence indicates that this method increases screening rates without causing harm.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores a new way to boost colon cancer screening rates through innovative communication methods. Unlike the usual reminder texts, this trial tests a "bundled messaging" approach, which includes interactive texts, mailed letters, and clinician reminders. This multi-channel strategy aims to engage patients more effectively, potentially leading to higher screening participation and earlier detection. By varying the messaging content, the trial seeks to uncover which communication style best encourages patients to get screened. This could lead to more personalized and effective public health strategies for colon cancer prevention.

What evidence suggests that this trial's treatments could be effective for improving adherence to colorectal cancer screening?

This trial will compare different methods to increase colorectal cancer screening rates. The control group will receive a simple text message reminder. Meanwhile, participants in the experimental arms—Messaging Groups A, B, and C—will receive a series of outreach messages, including texts with two-way messaging capabilities, mailed letters, and reminders to their clinicians. Studies have shown that using multiple reminders together can effectively increase screening rates for colorectal cancer. Specifically, one study found that sending reminders through texts and mailed letters significantly boosted the number of people completing their screenings. Another study demonstrated that these methods worked well in community clinics to encourage more people to get screened. The evidence suggests that these reminders can raise screening rates from as low as 5% to as high as 35%. Overall, combining reminders appears promising in helping more people complete these important screenings on time.12678

Who Is on the Research Team?

IR

Ilana Richman, MD

Principal Investigator

Yale University

Are You a Good Fit for This Trial?

This trial is for adults who are patients at Cornell Scott Hill Health with either a primary care doctor or more than one adult medicine visit in the past year. It's also for those with an abnormal stool test but no follow-up colonoscopy within 90 days, and those with pending orders for colorectal screening tests not yet completed.

Inclusion Criteria

I was ordered a colonoscopy or stool test for colorectal cancer screening but haven't completed it yet.
I am a current patient at Cornell Scott Hill Health.
I had a positive stool test for cancer screening but didn't get a follow-up colonoscopy within 90 days.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants receive outreach messages to improve adherence to colorectal cancer screening

3 months
Messages sent at 7, 14, 21, and 90 days

Follow-up

Participants are monitored for completion of colorectal cancer screening

6 months

What Are the Treatments Tested in This Trial?

Interventions

  • Bundled messaging intervention

Trial Overview

The study is testing a bundled messaging intervention to see if it helps people stick to recommended colorectal cancer screenings. Participants will be divided into four groups to compare different approaches.

How Is the Trial Designed?

4

Treatment groups

Experimental Treatment

Active Control

Group I: Messaging Group CExperimental Treatment1 Intervention
Group II: Messaging Group BExperimental Treatment1 Intervention
Group III: Messaging Group AExperimental Treatment1 Intervention
Group IV: Control-Usual CareActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Yale University

Lead Sponsor

Trials
1,963
Recruited
3,046,000+

Citations

Bundling Colorectal Cancer Screening Outreach ...

Models for “bundled” screening, linking one cancer screening test with other services, have gained attention for their potential as an effective ...

Bundled Approach to Improve Colorectal cancer in Primary ...

This demonstrates that the implemented strategies effectively improved screening uptake at the community-oriented primary care clinic.

Effect of a Digital Health Intervention on Receipt ...

The primary outcome was chart-verified completion of CRC screening within 24 weeks. Secondary outcomes were ability to state a screening ...

study protocol for a hybrid type I trial | BMC Health Services ...

Based on our prior studies (33–37), we anticipate CRC screening rates will be between 5 and 12% in usual care and 10–35% in the mPATH®-CRC arm, ...

An RCT to Increase Breast and Colorectal Cancer Screening

The tailored intervention simultaneously supporting both breast and colon cancer screenings significantly improved rates of obtaining one of the screenings and ...

Implementation Intentions and Colorectal Screening

The 61% of participants who received a provider recommendation for CRC screening were not more likely to complete CRC screening (50.6% completed screening among ...

NCT07345676 | Colorectal Cancer Screening Outreach

Intervention/Treatment, Behavioral : Bundled messaging intervention. A bundled intervention of text message, letter, and provider reminder.

Colorectal cancer screening in a safety-net health system

White, English-speaking patients had lowest odds of colorectal cancer screening. · Substance use and mental health disorders associated with worse screening odds ...